Palvella Therapeutics, Inc. (PVLA)
123.46
+3.08
(+2.56%)
USD |
NASDAQ |
Apr 02, 16:00
123.21
-0.25
(-0.20%)
After-Hours: 20:00
Palvella Therapeutics Shareholders Equity (Quarterly) : 27.98M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 1.017B |
| Gossamer Bio, Inc. | -122.76M |
| Agenus, Inc. | -271.11M |
| Novavax, Inc. | -127.75M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.56M |
| Total Liabilities (Quarterly) | 31.58M |
| Debt to Equity Ratio | 0.6573 |
| Current Ratio | 5.200 |
| Net Debt Paydown Yield | -0.28% |